# Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash Page: https://stenobird.com/podcast/business-of-biotech-123501/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash Text version: https://stenobird.com/podcast/business-of-biotech-123501/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.md Podcast: [Business Of Biotech](https://stenobird.com/podcast/business-of-biotech-123501) Published: 2026-03-23T10:00:00+00:00 Episode link: https://www.buzzsprout.com/1011661/episodes/18874087-commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.mp3 Audio file: https://www.buzzsprout.com/1011661/episodes/18874087-commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash Duration seconds: 3057 ## Resource We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech we're speaking with Alan Bash, President, Carvykti, at Legend Biotech, about how Carvykti became a blockbuster, category-leading CAR T therapy for multiple myeloma. Alan talks about manufacturing and delivering an autologous cell therapy at commercial scale, Legend Biotech's partnership with Johnson & Johnson, lessons he learned at Bristol Myers Squibb, Checkmate Pharmaceuticals, and ... ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/business-of-biotech-123501/commercializing-car-t-cell-therapy-with-legend-biotech-s-alan-bash.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.